Pathline Labs launches COVID-19|Influenza A/B Combo Testing
Pathline Labs, a leading provider of sub-specialized anatomic pathology, has added Coronavirus Disease testing with Influenza A/B testing for combination testing at its Ramsey, New Jersey facility. The tests are administered via nasal/oropharyngeal swab and can be completed with a singular swab for one combination test. Providing a testing option to identify both COVID-19 and Influenza A/B.
“We were able to quickly pivot from our core business of providing pathology and diagnostic testing for variety of specialties, to be able to provide a highly accurate COVID-19|Influenza Combo test,” said Frank Moser, CEO of Pathline Labs.
Pathline Labs Medical Director, Gregory S. Henderson, MD, PhD, and Gaurav Rajoria, Molecular Manager, oversaw the development of the Thermo Fisher COVID-19|Influenza A/B Combo test, which is FDA-approved with an accuracy rate of 99 percent or higher. It is a test used by reference laboratories and is allowing Pathline to conduct higher volumes of testing with a 24-36 hour turn around time.
“Rapid and accurate testing is the single most important tool for helping slow the spread of this disease, and our team has moved swiftly to launch this testing for our patients and our physician clients who are on the front lines of care.” said Dr. Henderson.
About Pathline Labs
Headquartered in Ramsey, NJ, Pathline is a leading provider of laboratory testing services for a wide range of specialities, with exceptional support and turnaround times. Backed by a team of highly trained, board-certified pathologists and Ph.D. level scientists, its full-service pathology lab has provided diagnostic testing, information and technical services to clinical and physician labs for more than 40 years.
Tests are available to current Pathline clients nationwide. Please contact Pathline Client Services for more information. 877.477.4214